Movement Disorders (revue) - Checkpoint (Ncbi)

Index « Mesh.i » - entrée « Pain Measurement »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Pain Management < Pain Measurement < Pain Threshold  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 51.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000135 (1999) B. Jabbari [États-Unis] ; A. SalardiniPainful tonic/dystonic spasms in Sjogren's syndrome.
000174 (1999) D. Tarsy [États-Unis] ; E R FirstPainful cervical dystonia: clinical features and response to treatment with botulinum toxin.
000508 (2001) P C Jedynak [France] ; C. Tranchant ; D Z De BeylProspective clinical study of writer's cramp.
000552 (2001) F. Tergau [Allemagne] ; S. Wischer ; C. Wolf ; W. PaulusTreatment of restless legs syndrome with the dopamine agonist alpha-dihydroergocryptine.
000C61 (2003) Daniel S. Sa [Canada] ; Angela Mailis-Gagnon ; Keith Nicholson ; Anthony E. LangPosttraumatic painful torticollis.
000C83 (2004) Connie Marras [Canada] ; Anthony Lang ; Murray Krahn ; George Tomlinson ; Gary NaglieQuality of life in early Parkinson's disease: impact of dyskinesias and motor fluctuations.
000D70 (2004) John A. Chaddock [Royaume-Uni] ; John R. Purkiss ; Frances C G. Alexander ; Sarah Doward ; Sarah J. Fooks ; Lorna M. Friis ; Yper H J. Hall ; Elizabeth R. Kirby ; Nicola Leeds ; Hilary J. Moulsdale ; Anthony Dickenson ; G Mark Green ; Wahida Rahman ; Rie Suzuki ; Michael J. Duggan ; Conrad P. Quinn ; Clifford C. Shone ; Keith A. FosterRetargeted clostridial endopeptidases: inhibition of nociceptive neurotransmitter release in vitro, and antinociceptive activity in in vivo models of pain.
000D74 (2004) Kai Wohlfarth [Allemagne] ; Knut Kampe ; Hans BigalkePharmacokinetic properties of different formulations of botulinum neurotoxin type A.
001010 (2005) Regina Katzenschlager [Royaume-Uni] ; Andrew Hughes ; Andrew Evans ; Alice J. Manson ; Marion Hoffman ; Lesley Swinn ; Hilary Watt ; Kailash Bhatia ; Niall Quinn ; Andrew J. LeesContinuous subcutaneous apomorphine therapy improves dyskinesias in Parkinson's disease: a prospective study using single-dose challenges.
001177 (2005) Daniel Truong [États-Unis] ; Drake D. Duane ; Joseph Jankovic [États-Unis] ; Carlos Singer ; Lauren C. Seeberger ; Cynthia L. Comella ; Mark F. Lew ; Robert L. Rodnitzky ; Fabio O. Danisi ; James P. Sutton ; P David Charles ; Robert A. Hauser ; Geoffrey L. SheeanEfficacy and safety of botulinum type A toxin (Dysport) in cervical dystonia: results of the first US randomized, double-blind, placebo-controlled study.
001202 (2005) Lisa M. Benrud-Larson [États-Unis] ; Paola Sandroni ; Anette Schrag ; Phillip A. LowDepressive symptoms and life satisfaction in patients with multiple system atrophy.
001366 (2005) Christine Brefel-Courbon [France] ; Pierre Payoux ; Claire Thalamas ; Fabienne Ory ; Isabelle Quelven ; François Chollet ; Jean Louis Montastruc ; Olivier RascolEffect of levodopa on pain threshold in Parkinson's disease: a clinical and positron emission tomography study.
001705 (2006) Karin Stiasny-Kolster [Allemagne] ; Ralf Kohnen ; Jens Carsten Möller ; Claudia Trenkwalder ; Wolfgang H. OertelValidation of the "L-DOPA test" for diagnosis of restless legs syndrome.
001836 (2006) Gea Drost [Pays-Bas] ; Aad Verrips ; Baziel G M. Van Engelen ; Dick F. Stegeman ; Machiel J. ZwartsInvoluntary painful muscle contractions in Satoyoshi syndrome: a surface electromyographic study.
001889 (2006) Cristina Tassorelli [Italie] ; Francesca Mancini ; Laura Balloni ; Claudio Pacchetti ; Giorgio Sandrini ; Giuseppe Nappi ; Emilia MartignoniBotulinum toxin and neuromotor rehabilitation: An integrated approach to idiopathic cervical dystonia.
001959 (2007) Jaime Kulisevsky [Espagne] ; Berta Pascual-Sedano ; Manel Barbanoj ; Alexandre Gironell ; Javier Pagonabarraga ; Carmen García-SánchezAcute effects of immediate and controlled-release levodopa on mood in Parkinson's disease: A double-blind study.
001D51 (2007) Richard M. Trosch [États-Unis] ; Charles H. Adler ; Eric J. PappertBotulinum toxin type B (Myobloc) in subjects with hemifacial spasm: results from an open-label, dose-escalation safety study.
001D93 (2007) Laura Bonanni [Italie] ; Astrid Thomas ; Sara Varanese ; Vincenzo Scorrano ; Marco OnofrjBotulinum toxin treatment of lateral axial dystonia in Parkinsonism.
001F79 (2008) Eric J. Pappert [États-Unis] ; Terry GermansonBotulinum toxin type B vs. type A in toxin-naïve patients with cervical dystonia: Randomized, double-blind, noninferiority trial.
001F92 (2008) Alexander G. Munts [Pays-Bas] ; Anne-Fleur Van Rootselaar ; Johan N. Van Der Meer ; Johannes H T M. Koelman ; Jacobus J. Van Hilten ; Marina A J. TijssenClinical and neurophysiological characterization of myoclonus in complex regional pain syndrome.
002182 (2008) Laurence Nègre-Pagès [France] ; Wafa Regragui ; Didier Bouhassira ; Héléne Grandjean ; Olivier RascolChronic pain in Parkinson's disease: the cross-sectional French DoPaMiP survey.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Ncbi/Checkpoint
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/Mesh.i -k "Pain Measurement" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/Mesh.i  \
                -Sk "Pain Measurement" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Checkpoint/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Ncbi
   |étape=   Checkpoint
   |type=    indexItem
   |index=    Mesh.i
   |clé=    Pain Measurement
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024